In 2023, the hospital discharge rate for dermatitis, eczema, and papulosquamous disorders in Canada was 4.3 per hundred thousand persons. Forecasts from 2024 to 2028 show a stable trend, maintaining a rate of 4.4 until 2027, with a slight decrease to 4.3 in 2028. Year-on-year variations remain minimal, indicating consistent incidence rates over these years. The five-year compound annual growth rate (CAGR) reflects negligible change, suggesting a stable healthcare impact from these conditions.
Future trends to watch include potential changes in healthcare policies, treatment advancements, and demographic shifts which could influence discharge rates. Additionally, increased awareness and preventive measures could play a crucial role in managing these conditions.
